ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO165

Association of Urinary Phosphate Excretion and Osteoporosis in Patients with CKD: Result from KNOW-CKD

Session Information

  • CKD-MBD: Clinical
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Jo, Yewon, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)
  • Park, Sung Joon, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)
  • Huh, Hyuk, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)
  • Kim, Taehee, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)
  • Kim, Yeong Hoon, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)
  • Kim, Yunmi, Inje University Busan Paik Hospital, Busan, Korea (the Republic of)

Group or Team Name

  • KNOW-CKD (The KoreaN Cohort Study on the Outcome of Chronic Kidney Disease Patients).
Background

The mechanism of osteoporosis is more complex in patients with chronic kidney disease (CKD) than general population because of accompanying chronic kidney disease-mineral bone disorder. We aimed to investigate the association of ability to handling urinary phosphate excretion and osteoporosis.

Methods

We analyzed 1,647 patients who were enrolled in the KNOW-CKD and have baseline 24-hour urinary phosphate value and dual-energy x-ray absorptiometry results. The subjects were divided into three groups according to tertile of urinary phosphate excretion. Osteoporosis was defined as T-score of -2.5 or less for one of L1 spine, total hip, or femur neck. The association of osteoporosis and urinary phosphate excretion was evaluated.

Results

The patients with higher urinary phosphate excretion tended to be younger, have higher body mass index and higher estimated glomerular filtration rate (eGFR), lower serum phosphate level. The osteoporosis was observed in 88 patients (16.0%), 31 patients (5.7%), and 14 patients (2.5%) for 1st (< 494mg), 2nd (494-660 mg), and 3rd (>660mg) tertile, respectively. In multivariate logistic regression analysis adjusted for age, sex, body mass index, hemoglobin, serum albumin, phosphate, calcium, and eGFR, patients belonged to 2nd tertile (odds ratio 0.543, 95% confidence interval 0.338-0.857, p = 0.010), and 3rd tertile (odds ratio 0.438, 95% confidence interval 0.223-0.812, p = 0.012) showed lower risk of osteoporosis compared to the patients in 1st tertile. In the subgroup analysis, the risk of osteoporosis was not significantly different among patients with CKD 1-2, however the decreasing risk of osteoporosis according to the tertile of urinary phosphate excretion was more prominent among patients with CKD 3-4.

Conclusion

Higher urinary phosphate excretion was associated with lower risk of osteoporosis in patients with CKD.

Funding

  • Government Support – Non-U.S.